These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 6828286)
1. Clinical correlates of circulating immune complex levels in advanced lung cancer. A discrimination analysis. Fekete B; Füst G; Pál A; Angyal I; Jakab A; Merétey K; Falus A; Török K; Szegedi G; Kávai M; Puskás E; Csécsi-Nagy M; Szabó T; Lenkey A; Misz M Oncology; 1983; 40(2):106-10. PubMed ID: 6828286 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer. Füst G; Fekete B; Angyal I; Jakab A; Pál A; Merétey K; Falus A; Török K; Szegedi G; Kávai M; Puskás E; Csécsi-Nagy M; Szabó T; Lenkey A; Misz M J Immunol Methods; 1981; 46(3):259-76. PubMed ID: 6975788 [TBL] [Abstract][Full Text] [Related]
4. A study of the material inhibiting EAC-rosette formation in the sera of patients with nephropathies. Smith MD; Verroust PJ; Adam C; Galceran M; Morel-Maroger L Clin Exp Immunol; 1977 Dec; 30(3):364-9. PubMed ID: 606450 [TBL] [Abstract][Full Text] [Related]
5. Detection of circulating immune complexes in patients with glomerulonephritis. Szewczyk Z; Falkiewicz K; Kopeć W Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):577-81. PubMed ID: 373683 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma. Barkas T; AL-Khateeb SF; Irvine WJ; Davidson NM; Roscoe P Clin Exp Immunol; 1976 Aug; 25(2):270-9. PubMed ID: 986262 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera. Howat JM; Moore M; Hilton AM; Kimber I Immunology; 1979 Jun; 37(2):467-75. PubMed ID: 468310 [TBL] [Abstract][Full Text] [Related]
12. Significance of circulatory immune complexes in thromboangiitis obliterans (Buerger's disease). Gulati SM; Saha K; Kant L; Thusoo TK; Prakash A Angiology; 1984 May; 35(5):276-81. PubMed ID: 6426348 [TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in patients with melanoma. Sztaba-Kania M; Jassem J; Piskorzyńska M; Kondrat W Neoplasma; 1981; 28(4):491-6. PubMed ID: 7027060 [TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro. Crawhall JC Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125 [TBL] [Abstract][Full Text] [Related]
15. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men. Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887 [TBL] [Abstract][Full Text] [Related]
16. [Immunological studies of glomerulonephritis]. Belovezhdov N; Altŭnkova I Vutr Boles; 1981; 20(4):38-46. PubMed ID: 7303639 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies. Poulton TA; Mooney NA; Nineham LJ; Hay FC Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605 [TBL] [Abstract][Full Text] [Related]
18. [Inhibition of EA and EAC rosette formation by sera of patients with vesical schistosomiasis]. De Simone C; Rebuzzi E; Marianella RM; Carini L; Elmi AS; Nuti M Quad Sclavo Diagn; 1978 Dec; 14(4):443-50. PubMed ID: 757619 [TBL] [Abstract][Full Text] [Related]
19. Analysis of sera from ovarian cancer patients for immune complexes. Witkin SS; Bongiovanni AM; Armbruster T; Birnbaum S; Caputo T J Clin Lab Immunol; 1984 Jun; 14(2):65-8. PubMed ID: 6748047 [TBL] [Abstract][Full Text] [Related]